- Home
- BCRX vs UNIT Comparison
BCRX vs UNIT Comparison
Compare BCRX & UNIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- UNIT
- Stock Information
- Founded
- BCRX 1986
- UNIT 2015
- Country
- BCRX United States
- UNIT United States
- Employees
- BCRX N/A
- UNIT N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- UNIT Real Estate Investment Trusts
- Sector
- BCRX Health Care
- UNIT Real Estate
- Exchange
- BCRX Nasdaq
- UNIT Nasdaq
- Market Cap
- BCRX 1.4B
- UNIT 1.3B
- IPO Year
- BCRX 1994
- UNIT N/A
- Fundamental
- Price
- BCRX $6.87
- UNIT $6.41
- Analyst Decision
- BCRX Strong Buy
- UNIT Hold
- Analyst Count
- BCRX 11
- UNIT 5
- Target Price
- BCRX $19.00
- UNIT $6.56
- AVG Volume (30 Days)
- BCRX 7.8M
- UNIT 2.7M
- Earning Date
- BCRX 11-03-2025
- UNIT 11-04-2025
- Dividend Yield
- BCRX N/A
- UNIT N/A
- EPS Growth
- BCRX N/A
- UNIT 1035.15
- EPS
- BCRX N/A
- UNIT 8.00
- Revenue
- BCRX $599,816,000.00
- UNIT $1,610,627,000.00
- Revenue This Year
- BCRX $41.57
- UNIT $97.96
- Revenue Next Year
- BCRX $6.25
- UNIT $63.33
- P/E Ratio
- BCRX N/A
- UNIT $0.78
- Revenue Growth
- BCRX 45.38
- UNIT 38.94
- 52 Week Low
- BCRX $6.00
- UNIT $5.30
- 52 Week High
- BCRX $11.31
- UNIT $10.48
- Technical
- Relative Strength Index (RSI)
- BCRX 43.58
- UNIT 56.89
- Support Level
- BCRX $6.51
- UNIT $5.57
- Resistance Level
- BCRX $7.22
- UNIT $6.72
- Average True Range (ATR)
- BCRX 0.27
- UNIT 0.40
- MACD
- BCRX 0.01
- UNIT 0.08
- Stochastic Oscillator
- BCRX 41.15
- UNIT 69.02
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About UNIT Uniti Group Inc.
Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.